Ranibizumab, in combination with prompt verteporfin photodynamic therapy, is more effective in treating polypoidal choroidal vasculopathy compared with ranibizumab monotherapy, according to a study ...
Pulsatile polypoidal vessel in polypoidal choroidal vasculopathy is an important characteristic that has not been reported with any other chorioretinal diseases and could assist in understanding the ...
A 71-year-old Indian male patient presented to the retina–vitreous service of our tertiary care hospital with the complaints of progressive decrease in vision in the right eye over the past 6 months.
Please provide your email address to receive an email when new articles are posted on . The retrospective study included 36 eyes of 36 patients with a mean age of 67.8 years who underwent combined PDT ...
To investigate the development of polypoidal lesions using indocyanine green angiography (IA) in eyes with typical age-related macular degeneration (AMD). We retrospectively reviewed the medical ...
"Polypoidal choroidal vasculopathy"DelveInsight's,“Polypoidal choroidal vasculopathy - Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in ...
Credit: Getty Images. Brolucizumab demonstrated superior anatomic results and maintained best corrected visual acuity (BCVA) in patients with polypoidal choroidal vasculopathy (PCV) at week 96 of the ...
MELBOURNE, Australia, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback